Eli Lilly to end 2024 among best in Big Pharma; Novo among worst
Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...